Blog

Katzenell Dimant /

IBT’s monumental effort to promote neurotechnology

   

photo

As you may know our firm has been a strategic partner of Israel Brain Technologies (IBT) since its inception back in 2011, and we are proud of our ongoing contribution to IBT’s monumental effort to promote advances in neurotechnology.

This month will see the culmination of IBT’s activities, as Brainnovations – IBT’s launchpad program, enters its final phase and the talented participants prepare for presenting their accomplishments before angels, VC’s, life science multinationals, incubators and other investors at the upcoming demo day.

At this time Israel Brain Technologies has announced that it is accepting applications to Brainnovations’ 2nd cycle. IBT is looking for outstanding entrepreneurs and inventors with promising technologies to join the program.

Brainnovations is a unique accelerator program that provides tailored education, mentoring and support to early stage projects in the brain space. For the duration of the program participants receive one-on-one consultations and support from world class mentors, are guided by industry experts on the ins and outs of establishing a life science startup, and gain access to IBT’s extensive network of opinion leaders, research institutions and investors and more.

If this sounds interesting for you or anyone you know please share this message and good luck applying – it’s an amazing opportunity!

Application deadline: March 19, 2016.

For more information and to apply, please see below and attached, or click here.


Einat Katzenell 300

Einat Katzenell offers strategic and practical advice to hi-tech, life sciences and biotechnology entrepreneurs, investors, early-stage and mature companies, academic institutions and business ventures, and is widely regarded an industry insider and a leader in her field.

More posts by Einat here.

einat@kdlaw.co.il   +972.9.9500555   LinkedIn


DISCLAIMER: Blog posts are not designed to provide legal advice or create a lawyer-client relationship. You should not take action based on this content.

SHARE:

read more in: